Research News

The Translational Medicine Research Team of DICP Visited the First Affiliated Hospital of Zhengzhou University

Posted: 2016-12-12

Under the coordination of the Prof. YANG Shengli (Academician) and Prof. XU Guowang, on December 8th, 2016, 11 experts of Dalian Institute of Chemical Physics (DICP), Chinese Academy of Sciences in the translational medical field visited the First Affiliated Hospital of Zhengzhou University (FAHZU) for the annual-conference of the cooperative projects. More than 50 clinical physicians from FAHZU including the President KAN Quancheng, the secretary ZHANG Shuijun, and the vice Presidents LIU Zhangsuo and WEN Jianguo et al. participated in the conference.

President KAN warmly greeted the guests and looked forward to the success of bilateral cooperation. Under the chair of Prof. ZHANG Yi and Prof. XU Guowang, the coordinators and scientists of 13 cooperation projects reported the progress of the related research work. After Prof. XU briefly introduced four platforms including proteomics, metabolomics, microfluidic microarrays and translational medicine in DICP, the clinical team of FAHZU introduced their new research subjects and clinical requirements, and two sides of scientists discussed the future possible cooperation fields. Finally, Prof. YANG Shengli summarized the conference, he encouraged the scientists of DICP to select research subjects from clinic practice and strengthen the integration of multiple omics platforms to meet the clinical needs and contribute to the health improvement.

This conference was greatly successful and got a very warm exchange atmosphere. All participants showed a strong enthusiasm to discuss the interested translational medicine research subjects. It can be expected that the cooperation between DICP and FAHZU will have a bright future. (Text and Imaged by YU Hao)

 

  • Contact
    Group 1808
  • Reference
  • Related Article